We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Tumour radiobiology
Digital Poster
Radiobiology
Perirenal Fat CT Radiomics-Based Survival Model for Upper Tract Urothelial Carcinoma: Integrating Texture Features with Clinical Predictors
Abdulrahman Al Mopti, United Kingdom
E25-290
Suppression of radiation-induced migration of non-small cell lung cancer with Microbeam Radiation Therapy (MRT)
Marina Santiago Franco, Germany
E25-1888
3D MedNext Model for the Automated Delineation of High Metabolic Regions in Nasopharyngeal Carcinoma on Computed Tomography Images
Guanqun Zhou, China
E25-1927
Carbon-ion radiotherapy inhibits lung cancer cell intravasation by regulating PGF methylation level
Rui Li, China
E25-2241
The orphan genes CCDC97 is involved in radiotherapy response in ER+ breast cancer cells.
Monica Mangoni, Italy
E25-2487
Genomic Profiling In Radioresistant Bladder Cancer Cell Lines
Taha Lodhi, United Kingdom
E25-2568
Sertraline as potential anticancer treatment in patients with NSCLC is not affecting the standard of care toxicity profile
Kim Kampen, The Netherlands
E25-2602
MitoTam as OXPHOS inhibitor: reducing hypoxia in solid tumors
Anne Beerkens, The Netherlands
E25-2606
Hypoxic tumor cells acquire a cellular quiescence phenotype that protects them against radiation-induced cell death
Apostolos Menegakis, The Netherlands
E25-2637
Inhibition of polymerase theta overcomes replication-associated radioresistance in triple-negative breast cancer cell lines
Marie Vogt, Germany
E25-2744
Dosimetric and radiobiological impact of patient setup errors in intensity-modulated radiotherapy for esophageal cancer
Jiahuan Cai, China
E25-2746
Clinical correlation of ERCC4 gene polymorphism with survival outcome and toxicities in post-operative oral cavity cancers
Ritusha Mishra, India
E25-338
Tumor suppressor gene IRF2BPL regulating radiosensitivity of esophageal squamous cell carcinoma through NOTCH pathway
cong liu, China
E25-3098
Identification of Twist1 and Mylk overexpression in migratory phenotypes of pancreatic cancer
Manuela Feyereisen, Germany
E25-3382
Lower level of expression od Bcl-2 is associated with local recurrence after postoperative radiotherapy for breast cancer patients
Sandra Radenkovic, Serbia
E25-3401
Pre-clinical data to rationalize the combination of new hormone therapy with PARP inhibitors in prostate cancer
Wael Mansour, Germany
E25-3450
Development and validation of a radiobiological model incorporating tumour perfusion and oxygenation characteristics
Yiannis Roussakis, Cyprus
E25-3527
Expression of ERCC5 gene and its correlation with clinical and pathological parameters in Cervical Cancer
HIMANSHU MISHRA, India
E25-3678
Exploring Dose-Escalated ultra-hypofractionation in Breast Cancer Radiotherapy: an In-Silico, biological-driven study
Denis Panizza, Italy
E25-3835
Enhancing the efficacy of hyperthermia in cancer treatment through the combination with carfilzomib
Fernando Enrique Lobo Cerna, The Netherlands
E25-3969
Evaluation of biocompatible gold/silver nanoparticles as radiosensitizers in a prostate cancer model
Maria Assunta Lacavalla, Italy
E25-4043
Differential Gene Expression in Murine Melanoma Following Ultra-High Dose Rate vs. Conventional Dose Rate Radiation Treatment
Wei Meng, USA
E25-4068
Clinical Evidence and Characteristics of Tumor Spatial Dose-Response Assessed in the Induction Chemotherapy of nasopharyngeal carcinoma patients
Shu Zhang, China
E25-462
Development and validation of a hypoxia-associated gene signature in patients with uterine cervical cancer.
Luisa Vanesa Biolatti, United Kingdom
E25-4132
In vitro study on the use of photosynthetic microalgae to radiosensitize hypoxic tumor cells
Beatriz Sanchez Nieto, Chile
E25-4133
Impact of Treatment Duration on Biologically Effective Dose in Stereotactic Radiosurgery - A Comparison Between Gamma Knife, Cyberknife and Truebeam
Matthew Skinner, USA
E25-4138
Meta-analysis of publicly available transcriptomics data reveals predictive biomarkers for neoadjuvant chemoradiotherapy in rectal cancer
Mladen Marinković, Serbia
E25-4395
FLASH Effect Mechanisms: Radiation Parameters and miRNA Insights from In Vitro Studies
Jonas Venius, Lithuania
E25-4409
Inhibitors of the enzyme Arginine Methyltransferase (PRMT) are identified as radiosensitizers in glioblastoma cells through a chemical screen
BEYZA NUR KÖSEOĞLU, Turkey
E25-4416
Modulation of radiation-induced bystander effects by microbeam radiation therapy in murine glioblastoma
Narayani Subramanian, Germany
E25-4494
Single-Cell Transcriptomics Reveals 3p Deletion-Associated Tumor Microenvironment and Chemoresistance in Head and Neck Squamous Cell Carcinoma
Siqi Xu, China
E25-971
Microbeam Radiation Therapy (MRT) and Minibeam Radiation Therapy (MBRT) improve local tumor control in a mouse tumor study
Thomas Schmid, Germany
E25-1093
Analysis of TCP and NTCP for different dose-fractionation schemes in the Stereotactic Radiotherapy of Brain Metastases
Yavuz Anacak, Turkey
E25-1282
Targeted breast cancer radiosensitization using polymeric aptamers
Paul Span, The Netherlands
E25-1352
Development of a colorectal adenocarcinoma mouse model to investigate in vivo diffusion of alpha-particle emitting daughters from Alpha-DaRT sources
Mélodie Cyr, Canada
E25-1453
3D printing-enhanced minibeam radiation therapy for targeted treatment of triple-negative breast cancer
Zengyi Fang, China
E25-1717